Prolonged diabetic ketoacidosis associated with canagliflozin

We report a case of a 63-year-old man who developed diabetic ketoacidosis (DKA) associated with canagliflozin, a sodium glucose co-transporter 2 (SGLT-2) inhibitor. He presented acutely unwell with a silent myocardial infarction, diverticulitis and DKA with a minimally raised blood glucose level. St...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloan, Gordon, Kakoudaki, Tania, Ranjan, Nishant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
New Disease or Syndrome: Presentations/Diagnosis/Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993060/
https://www.ncbi.nlm.nih.gov/pubmed/29899991
http://dx.doi.org/10.1530/EDM-17-0177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993060/
https://www.ncbi.nlm.nih.gov/pubmed/29899991
http://dx.doi.org/10.1530/EDM-17-0177

Ejemplares similares